Oxymorphone immediate-release tablets are used to relieve severe, acute pain (pain that begins suddenly, has a specific cause, and is expected to go away when the cause of the pain is healed) in people who are expected to need an opioid pain medication and who cannot be treated with other pain medications. It is grouped under the following drug class(es): Schedule II controlled substances. Its therapeutic use is listed as analgesics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Oximorphonum, 14-Hydroxydihydromorphinone, Dihydroxymorphinone, Numorphan and Opana. It is also listed for alternate use as: API Impurity, API Intermediate. It is listed as a controlled drug substance (Schedule II). Its PubChem CID is 5284604.
Oxymorphone
| CAS No | 76-41-5 |
|---|---|
| Molecular Formula | C17H19NO4 |
| Molecular Weight | 301.34 g/mol |
| Synonyms | (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Oxymorphone immediate-release tablets are used to relieve severe, acute pain (pain that begins suddenly, has a specific cause, and is expected to go away when the cause of the pain is healed) in people who are expected to need an opioid pain medication and who cannot be treated with other pain medications.
The listed CAS number is 76-41-5.
The listed molecular formula is C17H19NO4.
The listed molecular weight is 301.34 g/mol.
(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one.
The source lists Oximorphonum, 14-Hydroxydihydromorphinone, Dihydroxymorphinone, Numorphan and Opana.